Mahindra Manulife Small Cap Fund
The Scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity & equity related securities of small cap companies.
Growthvine rating: 4/5 — ranked #5 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹22.50 (as of 2026-08-21) |
|---|
| AUM | ₹4,930 Cr |
|---|
| Expense ratio | 1.60% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Krishna Sanghavi |
|---|
| Exit load | 1% for redemption within 3 months |
|---|
Performance & risk
| Sharpe ratio | 0.74 |
|---|
| Standard deviation | 19.66% |
|---|
| Max drawdown | -26.44% |
|---|
| Alpha | 4.85 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 95.4% of NIFTY Smallcap 250's upside and 75.0% of its downside.
Market cap allocation
| Large cap | 10.2% |
|---|
| Mid cap | 22.1% |
|---|
| Small cap | 67.7% |
|---|
Concentration
| Top 5 holdings | 15.9% |
|---|
| Top 10 holdings | 27.4% |
|---|
| Total holdings | 77 |
|---|
| Index overlap | 16.0% |
|---|
| Active share | 84.0% |
|---|
Top holdings
- Triparty Repo — 4.6%
- Neuland Laboratories Limited. — 3.9%
- Multi Commodity Exchange of India Ltd — 3.8%
- GARWARE HI-TECH FILMS LIMITED — 2.8%
- Jindal Saw Ltd. — 2.8%
- Oil India Limited — 2.5%
- Manappuram Finance Limited — 2.5%
- Divis Laboratories Ltd. — 2.4%
- COFORGE LIMITED — 2.2%
- VOLTAMP TRANSFORMERS LIMITED — 2.2%
Top sectors
- Industrial Products — 14.7%
- Pharma & Biotech — 12.9%
- Automobile — 10.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 15.9% | Q2 | #16 of 34 |
| 2025 | -2.7% | Q2 | #11 of 30 |
| 2024 | 28.0% | Q2 | #9 of 28 |
| 2023 | 57.2% | Q1 (Top) | #1 of 24 |